Membrane Technology Market to Represent a Value of $10,886.0 million in 2019 According to a new market report published by Persistence Market Research “Global Market Study on Membrane Technology in Pharmaceutical, Biopharma and Life Sciences: North America to Witness Highest Growth by 2019” the global membrane technology market for pharmaceutical, biopharma and life sciences is estimated at USD 7,029.9 million in 2014 and is expected to grow at a CAGR of 9.1% from 2014 to 2019, to reach an estimated value of USD 10,886.0 million in 2019. North America is the largest market for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. The U.S. is the world’s largest market for pharmaceutical and biopharmaceutical products. According to the European Federation of Pharmaceutical Industries and Associations, North America accounted for about 41% of global pharmaceutical sales in 2012. Similarly, in Europe, membrane technology is a rapidly growing sector with many associations, organizations and societies actively involved in expansion and implementation of this technology in various industries including pharmaceutical, biopharmaceutical and life sciences. However, Asia is the fastest growing region in the membrane technology market due to continuous development in pharmaceutical and biopharmaceutical industries. Checkout page @ https://www.persistencemarketresearch.com/checkout/3024 GE Healthcare Life Sciences and 3M are some of the leading players in the global membrane technology market in pharmaceutical, biopharma and life sciences. Other major players of the membrane technology market include Pall Corporation, Sartorius, Merck Millipore, Koch Membrane Systems Inc., Novasep, TriSep Corporation, Amazon Filters Ltd. and Advantec MFS.